| PubMed |
Abstract |
RScore(About this table) |
| 20101228 |
Tajima K, Ohashi R, Sekido Y, Hida T, Nara T, Hashimoto M, Iwakami S, Minakata K, Yae T, Takahashi F, Saya H, Takahashi K: Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene. 2010 Apr 1;29(13):1941-51. Epub 2010 Jan 18.
|
2(0,0,0,2) |
Details |
| 18720755 |
Tavciovski D, Davicevic Z: [Aortic stenosis: from diagnosis to optimal treatment] . Srp Arh Celok Lek. 2008 Mar-Apr;136(3-4):176-80.
Progression of the disease is an active process leading to forming of bone matrix and heavily calcified stiff cusps by inflammatory cells and osteopontin. |
1(0,0,0,1) |
Details |
| 19326399 |
Weismann D, Briese J, Niemann J, Gruneberger M, Adam P, Hahner S, Johanssen S, Liu W, Ezzat S, Saeger W, Bamberger AM, Fassnacht M, Schulte HM, Asa SL, Allolio B, Bamberger CM: Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma. J Pathol. 2009 Jun;218(2):232-40.
Gene array studies indicated that osteopontin (OPN) mRNA is highly expressed in adrenocortical carcinomas (ACCs). |
1(0,0,0,1) |
Details |